TY - JOUR
T1 - Cytokines drive the formation of memory-like NK cell subsets via epigenetic rewiring and transcriptional regulation
AU - Foltz, Jennifer A.
AU - Tran, Jennifer
AU - Wong, Pamela
AU - Fan, Changxu
AU - Schmidt, Evelyn
AU - Fisk, Bryan
AU - Becker-Hapak, Michelle
AU - Russler-Germain, David A.
AU - Johnson, Jeanette
AU - Marin, Nancy D.
AU - Cubitt, Celia C.
AU - Pence, Patrick
AU - Rueve, Joseph
AU - Pureti, Sushanth
AU - Hwang, Kimberly
AU - Gao, Feng
AU - Zhou, Alice Y.
AU - Foster, Mark
AU - Schappe, Timothy
AU - Marsala, Lynne
AU - Berrien-Elliott, Melissa M.
AU - Cashen, Amanda F.
AU - Bednarski, Jeffrey J.
AU - Fertig, Elana
AU - Griffith, Obi L.
AU - Griffith, Malachi
AU - Wang, Ting
AU - Petti, Allegra A.
AU - Fehniger, Todd A.
N1 - Publisher Copyright:
© 2024 the authors, some rights reserved; exclusive licensee american association for the advancement of Science.
PY - 2024/6/28
Y1 - 2024/6/28
N2 - Activation of natural killer (NK) cells with the cytokines interleukin-12 (IL-12), IL-15, and IL-18 induces their differentiation into memory-like (ML) NK cells; however, the underlying epigenetic and transcriptional mechanisms are unclear. By combining ATAC-seq, CITE-seq, and functional analyses, we discovered that IL-12/15/18 activation results in two main human NK fates: reprogramming into enriched memory-like (eML) NK cells or priming into effector conventional NK (effcNK) cells. eML NK cells had distinct transcriptional and epigenetic profiles and enhanced function, whereas effcNK cells resembled cytokine-primed cNK cells. Two transcriptionally discrete subsets of eML NK cells were also identified, eML-1 and eML-2, primarily arising from CD56bright or CD56dim mature NK cell subsets, respectively. Furthermore, these eML subsets were evident weeks after transfer of IL-12/15/18–activated NK cells into patients with cancer. Our findings demonstrate that NK cell activation with IL-12/15/18 results in previously unappreciated diverse cellular fates and identifies new strategies to enhance NK therapies.
AB - Activation of natural killer (NK) cells with the cytokines interleukin-12 (IL-12), IL-15, and IL-18 induces their differentiation into memory-like (ML) NK cells; however, the underlying epigenetic and transcriptional mechanisms are unclear. By combining ATAC-seq, CITE-seq, and functional analyses, we discovered that IL-12/15/18 activation results in two main human NK fates: reprogramming into enriched memory-like (eML) NK cells or priming into effector conventional NK (effcNK) cells. eML NK cells had distinct transcriptional and epigenetic profiles and enhanced function, whereas effcNK cells resembled cytokine-primed cNK cells. Two transcriptionally discrete subsets of eML NK cells were also identified, eML-1 and eML-2, primarily arising from CD56bright or CD56dim mature NK cell subsets, respectively. Furthermore, these eML subsets were evident weeks after transfer of IL-12/15/18–activated NK cells into patients with cancer. Our findings demonstrate that NK cell activation with IL-12/15/18 results in previously unappreciated diverse cellular fates and identifies new strategies to enhance NK therapies.
UR - http://www.scopus.com/inward/record.url?scp=85197202301&partnerID=8YFLogxK
U2 - 10.1126/sciimmunol.adk4893
DO - 10.1126/sciimmunol.adk4893
M3 - Article
C2 - 38941480
AN - SCOPUS:85197202301
SN - 2470-9468
VL - 9
JO - Science immunology
JF - Science immunology
IS - 96
M1 - eadk4893
ER -